Key result
Injection of undiluted papovavirus SV40 induced complement-fixing and neutralizing antibodies against structural antigens in all 4 monkeys, and against the T antigen in 3 monkeys.
Authors
Loading...
SV40 induces antibodies in monkeys; leaves open human immunogenicity, safety, and oncogenicity questions.
Vonka et al. (1967) studied Papovavirus SV40 infection (n=4). Undiluted papovavirus SV40 was evaluated on Development of complement-fixing and neutralizing antibodies against structural and T antigens. Injection of undiluted papovavirus SV40 induced complement-fixing and neutralizing antibodies against structural antigens in all 4 monkeys, and against the T antigen in 3 monkeys.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: